Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Monte Rosa Therapeutics to Present at Upcoming Investor and Industry Conferences | ||
By: GlobeNewswire - 30 May 2023 | Back to overview list |
|
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the company is scheduled to present at the following investor and industry events in June:
Webcasted presentations will be accessible via the “Events & Presentations” section of the company’s investor site at https://ir.monterosatx.com/, and an archived version will be made available for 90 days following the presentation.
CONTACT: Investors Shai Biran Monte Rosa Therapeutics ir@monterosatx.com Media Cory Tromblee Scient Public Relations media@monterosatx.com |
||
|
||
Copyright 2023 GlobeNewswire | Back to overview list |